Malignant hyperthermia (MH), or hyperthermie maligne , is a life-threatening pharmacogenetic disorder triggered primarily by volatile anesthetic gases and the muscle relaxant succinylcholine. It results in a hypermetabolic crisis due to an uncontrolled release of calcium from skeletal muscle cells. While rare, affecting roughly 1 in 5,000 to 1 in 50,000 anesthesia cases, it requires immediate recognition and treatment with dantrolene to prevent fatal complications.

MH is usually inherited in an autosomal dominant pattern, often involving mutations in the gene. Malignant Hyperthermia

Download — Hyperthermie Maligne Pptx

Malignant hyperthermia (MH), or hyperthermie maligne , is a life-threatening pharmacogenetic disorder triggered primarily by volatile anesthetic gases and the muscle relaxant succinylcholine. It results in a hypermetabolic crisis due to an uncontrolled release of calcium from skeletal muscle cells. While rare, affecting roughly 1 in 5,000 to 1 in 50,000 anesthesia cases, it requires immediate recognition and treatment with dantrolene to prevent fatal complications.

MH is usually inherited in an autosomal dominant pattern, often involving mutations in the gene. Malignant Hyperthermia

Send us your question or request

Tel  |  Email

+420 725 913 535
+420 702 142 452
info@satomar.cz
www.scangle.eu

Company

Satomar, s.r.o.
ID: 29201586
VAT ID: CZ29201586

Address

Karlova 37
614 00 Brno
Czech Republic